Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Konrad H Stopsack

Showing results (31-40 of 105) with videos related to

Pageof 11
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 2021
Abiraterone Acetate Induces CREB1 Phosphorylation and Enhances the Function of the CBP-p300 Complex, Leading to Resistance in Prostate Cancer CellsWenting Pan, Zhouwei Zhang, Hannah Kimball, et al.
The Prostate|August 25, 2018
Association of genetic variation of the six gene prognostic model for castration-resistant prostate cancer with survivalWanling Xie, Konrad H Stopsack, Sarah J Drouin, et al.
International Journal of Cancer|March 1, 2024
Healthy dietary patterns and risk of prostate cancer in men at high genetic riskYiwen Zhang, Konrad H Stopsack, Mingyang Song, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 4, 2019
Low Expression of the Androgen-Induced Tumor Suppressor Gene <i>PLZF</i> and Lethal Prostate CancerKonrad H Stopsack, Travis Gerke, Svitlana Tyekucheva, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 19, 2025
Western Dietary Pattern, Prudent Dietary Pattern, and Cancer-Specific Quality of Life in Prostate Cancer Survivors in the Health Professionals Follow-up StudyQi Hua, Scott R Bauer, Konrad H Stopsack, et al.
Cancer Prevention Research (Philadelphia, Pa.)|September 20, 2022
Differences in Prostate Cancer Transcriptomes by Age at Diagnosis: Are Primary Tumors from Older Men Inherently Different?Charlie D Zhou, Andreas Pettersson, Anna Plym, et al.
Molecular Cancer Research : MCR|December 13, 2022
The Prostate Stromal Transcriptome in Aggressive and Lethal Prostate CancerChaoran Ma, Yinglu Zhou, Giuseppe Nicolò Fanelli, et al.
British Journal of Cancer|October 29, 2023
Modifiable risk factors for subsequent lethal prostate cancer among men with an initially negative prostate biopsyXiaoshuang Feng, Yiwen Zhang, J Bailey Vaselkiv, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2022
Family History of Prostate and Breast Cancer Integrated with a Polygenic Risk Score Identifies Men at Highest Risk of Dying from Prostate Cancer before Age 75 YearsAnna Plym, Yiwen Zhang, Konrad H Stopsack, et al.
Plos One|April 29, 2024
Quantifying Y chromosome loss in primary and metastatic prostate cancer by chromosome paintingSai Harisha Rajanala, Romina Ghale, Subhiksha Nandakumar, et al.
Pageof 11

Showing results (31-40 of 105) with videos related to

Sort By:
Pageof 11
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 2021
Abiraterone Acetate Induces CREB1 Phosphorylation and Enhances the Function of the CBP-p300 Complex, Leading to Resistance in Prostate Cancer CellsWenting Pan, Zhouwei Zhang, Hannah Kimball, et al.
The Prostate|August 25, 2018
Association of genetic variation of the six gene prognostic model for castration-resistant prostate cancer with survivalWanling Xie, Konrad H Stopsack, Sarah J Drouin, et al.
International Journal of Cancer|March 1, 2024
Healthy dietary patterns and risk of prostate cancer in men at high genetic riskYiwen Zhang, Konrad H Stopsack, Mingyang Song, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 4, 2019
Low Expression of the Androgen-Induced Tumor Suppressor Gene <i>PLZF</i> and Lethal Prostate CancerKonrad H Stopsack, Travis Gerke, Svitlana Tyekucheva, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 19, 2025
Western Dietary Pattern, Prudent Dietary Pattern, and Cancer-Specific Quality of Life in Prostate Cancer Survivors in the Health Professionals Follow-up StudyQi Hua, Scott R Bauer, Konrad H Stopsack, et al.
Cancer Prevention Research (Philadelphia, Pa.)|September 20, 2022
Differences in Prostate Cancer Transcriptomes by Age at Diagnosis: Are Primary Tumors from Older Men Inherently Different?Charlie D Zhou, Andreas Pettersson, Anna Plym, et al.
Molecular Cancer Research : MCR|December 13, 2022
The Prostate Stromal Transcriptome in Aggressive and Lethal Prostate CancerChaoran Ma, Yinglu Zhou, Giuseppe Nicolò Fanelli, et al.
British Journal of Cancer|October 29, 2023
Modifiable risk factors for subsequent lethal prostate cancer among men with an initially negative prostate biopsyXiaoshuang Feng, Yiwen Zhang, J Bailey Vaselkiv, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2022
Family History of Prostate and Breast Cancer Integrated with a Polygenic Risk Score Identifies Men at Highest Risk of Dying from Prostate Cancer before Age 75 YearsAnna Plym, Yiwen Zhang, Konrad H Stopsack, et al.
Plos One|April 29, 2024
Quantifying Y chromosome loss in primary and metastatic prostate cancer by chromosome paintingSai Harisha Rajanala, Romina Ghale, Subhiksha Nandakumar, et al.
Pageof 11